| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040700139 |
| P356 | DOI | 10.1186/1471-2407-10-152 |
| P932 | PMC publication ID | 2876077 |
| P698 | PubMed publication ID | 20403178 |
| P5875 | ResearchGate publication ID | 43200562 |
| P2093 | author name string | Maria J Schymura | |
| Robert R German | |||
| John P Fulton | |||
| Rosemary D Cress | |||
| Jack L Finch | |||
| Mei-Chin Hsieh | |||
| Tiefu Shen | |||
| Amy R Kahn | |||
| Erik Stuckart | |||
| P2860 | cites work | Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). | Q30586030 |
| Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population | Q30714715 | ||
| Limits of observational data in determining outcomes from cancer therapy | Q31153256 | ||
| Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer | Q33318333 | ||
| Prostate cancer treatment and ten-year survival among group/staff HMO and fee-for-service Medicare patients | Q33773297 | ||
| Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment | Q33799110 | ||
| Treatment decisions for localized prostate cancer: asking men what's important | Q33843865 | ||
| National Comprehensive Cancer Network guidelines for the management of prostate cancer | Q34187291 | ||
| Radical prostatectomy versus watchful waiting in early prostate cancer | Q34418166 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study | Q34742544 | ||
| Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study | Q35091553 | ||
| Nonmedical factors in treatment selection | Q35123274 | ||
| Quality of life after treatment for prostate cancer | Q35131043 | ||
| Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer | Q36433781 | ||
| Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial | Q36841565 | ||
| The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment | Q36884863 | ||
| Survival following primary androgen deprivation therapy among men with localized prostate cancer | Q37104386 | ||
| Radical surgery versus radiation therapy in early prostatic carcinoma | Q39255402 | ||
| Factors that determine the treatment for local and regional prostate cancer | Q39421811 | ||
| Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study | Q44286367 | ||
| Cumulative cost pattern comparison of prostate cancer treatments | Q44528407 | ||
| Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate | Q44922422 | ||
| Racial/ethnic disparities in the treatment of localized/regional prostate cancer | Q44985477 | ||
| Geographic variation across veterans affairs medical centers in the treatment of early stage prostate cancer | Q45333337 | ||
| Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina. | Q46532776 | ||
| Trends and black/white differences in treatment for nonmetastatic prostate cancer | Q46832041 | ||
| Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer | Q47377189 | ||
| Treatment of localized prostate cancer in African-American compared with Caucasian men. Less use of aggressive therapy for comparable disease | Q48637334 | ||
| Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association | Q50109729 | ||
| Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. | Q51973359 | ||
| Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology | Q52861574 | ||
| Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. | Q52967287 | ||
| Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. | Q53446499 | ||
| Cost of care for elderly cancer patients in the United States. | Q53730492 | ||
| Factors Associated With Initial Therapy for Clinically Localized Prostate Cancer: Prostate Cancer Outcomes Study | Q59193486 | ||
| A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer | Q59265104 | ||
| A randomized trial of choice of treatment in prostate cancer: the effect of intervention on the treatment chosen | Q59830886 | ||
| Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study | Q70942924 | ||
| United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region | Q78390337 | ||
| Determinants of mortality following a diagnosis of prostate cancer in Veterans Affairs and private sector health care systems | Q79133372 | ||
| Survival associated with treatment vs observation of localized prostate cancer in elderly men | Q79428795 | ||
| Quality of life and satisfaction with outcome among prostate-cancer survivors | Q80917895 | ||
| Initial treatment patterns for clinically localized prostate cancer and factors associated with the treatment in Louisiana | Q81404618 | ||
| Immediate or deferred androgen deprivation for patients with prostate cancer not suitable for local treatment with curative intent: European Organisation for Research and Treatment of Cancer (EORTC) Trial 30891 | Q83170866 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 152 | |
| P577 | publication date | 2010-04-19 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1) | |
| P478 | volume | 10 |
| Q36414849 | A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States |
| Q40584866 | A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer |
| Q38728363 | African-American Men with Low-Risk Prostate Cancer: Modern Treatment and Outcome Trends |
| Q37003387 | Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study |
| Q34602118 | American trends in expectant management utilization for prostate cancer from 2000 to 2009. |
| Q35888211 | Comorbidities, treatment and ensuing survival in men with prostate cancer |
| Q89019054 | Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients |
| Q38162919 | Comparative effectiveness research in localized prostate cancer treatment |
| Q47813833 | Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology |
| Q47253086 | Detection of Local Recurrence with 3-Tesla MRI After Radical Prostatectomy: A Useful Method for Radiation Treatment Planning? |
| Q42669921 | Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia. |
| Q64066683 | Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence |
| Q36170995 | Historical prostate cancer screening and treatment outcomes from a single institution |
| Q37441122 | Improving couples' quality of life through a Web-based prostate cancer education intervention. |
| Q35037541 | Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: long-term follow-up |
| Q35459197 | Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive? |
| Q90227984 | Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play |
| Q47697932 | PSA testing without clinical indication for prostate cancer in relation to socio-demographic and clinical characteristics in the Danish Diet, Cancer and Health Study |
| Q41028107 | Patient comorbidity is associated with conservative treatment of localized prostate cancer |
| Q39396633 | Quality of care received and patient-reported regret in prostate cancer: Analysis of a population-based prospective cohort |
| Q86574950 | Racial disparities in prostate cancer care: is adherence to National Comprehensive Cancer Network guidelines good enough for our patients? |
| Q35368777 | Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohort |
| Q37178150 | Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. |
| Q34435885 | Recommendations on screening for prostate cancer with the prostate-specific antigen test |
| Q30844605 | Relative survival analysis using the Centers for Disease Control and Prevention's National Program of Cancer Registries Surveillance System Data, 2000-2007. |
| Q30541361 | Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database |
| Q39422186 | Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review |
| Q38958459 | Sociodemographic Disparities in Cure-Intended Treatment in Localized Prostate Cancer. |
| Q90065587 | Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study |
| Q38208193 | Survival following primary androgen deprivation therapy for localized intermediate- or high-risk prostate cancer: comparison with the life expectancy of the age-matched normal population |
| Q34102004 | The influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort study |
| Q64266611 | The role of radiotherapy in metastatic prostate cancer |
| Q35103578 | Three-dimensional external beam radiotherapy for prostate cancer increases the risk of hip fracture |
| Q55257317 | Trends in Treatment for Prostate Cancer in China: Preliminary Patterns of Care Study in a Single Institution. |
| Q37613018 | Type and dose of radiotherapy used for initial treatment of non-metastatic prostate cancer |
| Q37053006 | Types of chronic conditions combinations and initial cancer treatment among elderly Medicare beneficiaries with localised prostate cancer |
| Q50503378 | Utilization and predictors of expectant management among elderly men with low-and intermediate-risk localized prostate cancer in U.S. urological practice. |
| Q35577274 | Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer |
Search more.